BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

936 related articles for article (PubMed ID: 18367983)

  • 1. Herbal supplements and therapeutic drug monitoring: focus on digoxin immunoassays and interactions with St. John's wort.
    Dasgupta A
    Ther Drug Monit; 2008 Apr; 30(2):212-7. PubMed ID: 18367983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. St John's wort and depression: slight efficacy at best, many drug interactions.
    Prescrire Int; 2004 Oct; 13(73):187-92. PubMed ID: 15499702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. St. John's wort does not interfere with therapeutic drug monitoring of 12 commonly monitored drugs using immunoassays.
    Dasgupta A; Tso G; Szelei-Stevens K
    J Clin Lab Anal; 2006; 20(2):62-7. PubMed ID: 16538644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for interaction of kava and St. John's wort with drugs.
    Singh YN
    J Ethnopharmacol; 2005 Aug; 100(1-2):108-13. PubMed ID: 16005588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Chinese medicines Chan Su and Lu-Shen-Wan on serum digoxin measurement by Digoxin III, a new digoxin immunoassay.
    Reyes MA; Actor JK; Risin SA; Dasgupta A
    Ther Drug Monit; 2008 Feb; 30(1):95-9. PubMed ID: 18223469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of St. John's wort supplementation on ibuprofen pharmacokinetics.
    Bell EC; Ravis WR; Lloyd KB; Stokes TJ
    Ann Pharmacother; 2007 Feb; 41(2):229-34. PubMed ID: 17284505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of St John's wort on imatinib mesylate pharmacokinetics.
    Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
    Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin.
    Mueller SC; Uehleke B; Woehling H; Petzsch M; Majcher-Peszynska J; Hehl EM; Sievers H; Frank B; Riethling AK; Drewelow B
    Clin Pharmacol Ther; 2004 Jun; 75(6):546-57. PubMed ID: 15179409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction between St John's wort and an oral contraceptive.
    Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
    Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of St. John's wort (hypericum) during pregnancy and lactation.
    Dugoua JJ; Mills E; Perri D; Koren G
    Can J Clin Pharmacol; 2006; 13(3):e268-76. PubMed ID: 17085775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction.
    Izzo AA; Di Carlo G; Borrelli F; Ernst E
    Int J Cardiol; 2005 Jan; 98(1):1-14. PubMed ID: 15676159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [St. John's wort: a pharmaceutical with potentially dangerous interactions].
    Rätz AE; von Moos M; Drewe J
    Praxis (Bern 1994); 2001 May; 90(19):843-9. PubMed ID: 11407242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum)].
    Güzelcan Y; Scholte WF; Assies J; Becker HE
    Ned Tijdschr Geneeskd; 2001 Oct; 145(40):1943-5. PubMed ID: 11675976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of St John's wort (Hypericum perforatum) on cytochrome P-450 activity in perfused rat liver.
    Dostalek M; Pistovcakova J; Jurica J; Tomandl J; Linhart I; Sulcová A; Hadasova E
    Life Sci; 2005 Dec; 78(3):239-44. PubMed ID: 16125735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of metabolism-mediated herb-drug interactions.
    Na DH; Ji HY; Park EJ; Kim MS; Liu KH; Lee HS
    Arch Pharm Res; 2011 Nov; 34(11):1829-42. PubMed ID: 22139684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.